SCHEMBL26291623

SCHEMBL26291623

C=CC(=O)OCOc1ccc2cc(-c3cnccc3CC)oc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2E1 P05181 1/20 0.37
▸ CYP2C8 P10632 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RAB9A P51151 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ GLA P06280 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26291617 0.91 THRB (0.40) APPCYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL26291627 0.86 APP (0.37) APPCYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL26291461 0.86 RAB9A (0.40) RAB9AALDH1A1NPC1KDM4EGLA
SCHEMBL22245815 0.83 S1PR1 (0.35) APPCYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL26291695 0.82 ALDH1A1 (0.40) APPCYP1A2RAB9AALDH1A1NPC1
SCHEMBL25896587 0.80 CYP1A2 (0.33) APPCYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL26291620 0.78 S1PR1 (0.39) APPCYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL26291480 0.77 PTPN1 (0.47) APPCYP2C19RAB9AALDH1A1NPC1
SCHEMBL26291477 0.77 PTPN1 (0.47) APPCYP2C19RAB9AALDH1A1NPC1
SCHEMBL26291539 0.77 PTPN1 (0.58) APPCYP2C19RAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D APP 899/4885CYP1A2 1796/4885CYP2E1 2713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback